News

June 17, 2019June 17, 2019

Most Prostate Cancer Patients on Active Surveillance Don’t Follow Monitoring Guidelines, Study Shows

News

Most prostate cancer patients who choose to undergo active surveillance instead of treatment are not receiving the appropriate disease monitoring, bringing into question whether or not this is a ... Read more

June 13, 2019June 13, 2019

Study Shows How Prostate Cancer Cells Mimic Bone When They Metastasize

News

Prostate cancer cells can activate genes associated with bone formation and mimic bone cells’ behavior, allowing them to spread into bones. Those findings by by Duke University researchers, have ... Read more

June 12, 2019

Darolutamide/ADT Combo Delays Disease Worsening in Some PC, Phase 3 Trial Shows

News

Darolutamide in combination with androgen deprivation therapy (ADT) delays disease worsening in men with non-metastatic castration-resistant prostate cancer (nmCRPC) and stabilizes their quality of life without increasing the incidence ... Read more

June 6, 2019

Add-on Xtandi Prolongs Survival in Metastatic Hormone-sensitive PC, Trial Shows

News

Treatment with Xtandi (enzalutamide) and testosterone suppression prolonged the survival of men with metastatic hormone-sensitive prostate cancer in comparison with standard of care, according to early findings of a ... Read more

June 5, 2019

Trial Shows Erleada Can Prolong Metastatic Castration-sensitive PC Patients’ Lives

News

Adding Erleada (apalutamide), Janssen‘s next-generation androgen receptor inhibitor, to androgen deprivation therapy (ADT) can prolong life and extend the time without disease worsening in men with metastatic castration-sensitive prostate ... Read more

June 3, 2019

American and Russian Scientists Team Up in Search for Potential Biomarker for Metastatic Prostate Cancer

News

Funded by a $380,000 grant from the National Cancer Institute, researchers at the University at Buffalo (UB) in New York and Moscow State University in Russia are collaborating to ... Read more

May 30, 2019May 30, 2019

Patient Survey Sheds Light on Emotional and Overall Impact of Prostate Cancer

News

Men who are diagnosed with prostate cancer at later stages of the disease are more likely to say that their disease has affected several aspects of their life, including ... Read more

May 29, 2019May 29, 2019

RB1 Mutations Linked to Worse Outcomes in Prostate Cancer Patients, Study Finds

News

Men whose tumors contain mutations in the retinoblastoma (RB1) gene have higher risks of prostate cancer relapse and mortality while receiving first-line conventional anti-cancer therapies, a study says. According ... Read more

May 23, 2019May 23, 2019

Prostate Cancer Foundation Puts Patients on Path to Knowledge with Updated Guide, Resources

News

The Prostate Cancer Foundation (PCF) has released its comprehensive Prostate Cancer Patient Guide with the latest in diagnosis, research, treatments, and lifestyle factors for patients and caregivers. With contributions ... Read more

May 22, 2019May 22, 2019

Xtandi Extends Time to Disease Worsening in Certain Metastatic Prostate Cancer Patients – Without Added Side Effects – Study Shows

News

Xtandi (enzalutamide), an androgen receptor inhibitor, significantly delays disease progression — as assessed through radiological imaging — or death in metastatic hormone-sensitive prostate cancer (mHSPC) patients, a Phase 3 clinical trial ... Read more

Pin It on Pinterest